These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6144173)

  • 1. Effects of dopamine and dopamine antagonists on postprandial release of pancreatic polypeptide in dogs and in healthy volunteers.
    Linnestad P; Guldvog I; Schrumpf E
    Scand J Gastroenterol; 1983 Jan; 18(1):81-5. PubMed ID: 6144173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of alpha- and beta-adrenergic agonists and blockers on postprandial pancreatic polypeptide release in dogs.
    Linnestad P; Guldvog I; Schrumpf E
    Scand J Gastroenterol; 1983 Jan; 18(1):87-90. PubMed ID: 6144174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopaminergic suppression of pancreatic somatostatin secretion.
    Itoh M; Furman BL; Gerich JE
    Acta Endocrinol (Copenh); 1982 Sep; 101(1):56-61. PubMed ID: 6126981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cholinergic, adrenergic, and dopaminergic blockade on gastrin secretion in healthy subjects.
    Schrumpf E; Linnestad P
    Scand J Gastroenterol; 1982 Jan; 17(1):29-31. PubMed ID: 6127788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of intrarenal administration of dopamine on renin release in conscious dogs.
    Mizoguchi H; Dzau VJ; Siwek LG; Barger AC
    Am J Physiol; 1983 Jan; 244(1):H39-45. PubMed ID: 6336914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adrenergic modulation of the release of pancreatic polypeptide after intraduodenal and oral glucose in man.
    Flaten O; Myren J
    Scand J Gastroenterol; 1981; 16(6):781-7. PubMed ID: 6275494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopamine receptor blocking activity of sulpiride in the canine exocrine pancreas.
    Satoh Y; Satoh H; Honda F
    Jpn J Pharmacol; 1980 Oct; 30(5):689-99. PubMed ID: 7206375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The regulation of basal pancreatic polypeptide levels in dogs.
    Werther GA; Sperling MA; Joffe S; Murphy RF
    Regul Pept; 1987 Apr; 17(4):191-8. PubMed ID: 2884699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of histamine, H1 and H2 agonists, and H1 and H2 antagonists on postprandial pancreatic polypeptide release in dogs.
    Linnestad P; Guldvog I; Schrumpf E
    Scand J Gastroenterol; 1983 Mar; 18(2):165-8. PubMed ID: 6143392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-adrenoceptor and dopamine receptor antagonists do not block the slow inhibitory postsynaptic potential in sympathetic ganglia.
    Cole AE; Shinnick-Gallagher P
    Brain Res; 1980 Apr; 187(1):226-30. PubMed ID: 6244069
    [No Abstract]   [Full Text] [Related]  

  • 11. Dopamine and L-dopa: inhibition of thyrotropin-stimulated thyroidal thyroxine release.
    Maayan ML; Sellitto RV; Volpert EM
    Endocrinology; 1986 Feb; 118(2):632-6. PubMed ID: 2867890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of dopamine on neuromuscular transmission in the guinea-pig mesenteric artery.
    Fujisawa K
    Eur J Pharmacol; 1983 Aug; 92(1-2):105-12. PubMed ID: 6313381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro evidence for dopaminergic receptors in human renal artery.
    Ueda S; Yano S; Sakanashi M
    J Cardiovasc Pharmacol; 1982; 4(1):76-81. PubMed ID: 6176804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide YY antagonizes beta-adrenergic-stimulated release of insulin in dogs.
    Greeley GH; Lluis F; Gomez G; Ishizuka J; Holland B; Thompson JC
    Am J Physiol; 1988 Apr; 254(4 Pt 1):E513-7. PubMed ID: 2895586
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective activation by LY-141865 and apomorphine of presynaptic dopamine receptors in the rat kidney and influence of stimulation parameters in the action of dopamine.
    Lokhandwala MF; Steenberg ML
    J Pharmacol Exp Ther; 1984 Jan; 228(1):161-7. PubMed ID: 6694099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Responses of the canine hepatic arterial and portal venous vascular beds to dopamine.
    Richardson PD; Withrington PG
    Eur J Pharmacol; 1978 Apr; 48(4):337-49. PubMed ID: 206449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopaminergic and adrenergic influence on gastric acid and pepsin secretion stimulated by food. The role of vagal innervation.
    Guldvog I; Linnestad P; Schrumpf E; Berstad A
    Scand J Gastroenterol Suppl; 1984; 89():113-6. PubMed ID: 6429838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics of receptors for dopamine in the pars intermedia of the amphibian Xenopus laevis.
    Verburg-Van Kemenade BM; Tonon MC; Jenks BG; Vaudry H
    Neuroendocrinology; 1986; 44(4):446-56. PubMed ID: 3822075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of presynaptic inhibitory actions of various dopamine analogs on sympathetic neurotransmission in mongrel dogs.
    Lokhandwala MF; Buckley JP
    Life Sci; 1977 Feb; 20(3):507-16. PubMed ID: 190513
    [No Abstract]   [Full Text] [Related]  

  • 20. Relaxation by dopaminergic agonists in cerebral and peripheral arteries (in vitro).
    Oudart N; Sercombe R; Aubineau P; Boulu RG; Seylaz J
    Arch Int Pharmacodyn Ther; 1981 Aug; 252(2):196-209. PubMed ID: 7305558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.